Oslomed – Clinical Trial Site Organization

Cardiology - Clinical Trials | Oslomed Kraków

Cardiology

Cardiology is the branch of medicine focused on the diagnosis, treatment, and management of diseases and disorders of the heart and cardiovascular system, including coronary arteries, heart valves, heart muscle, cardiac rhythm, and blood circulation.

Heart Failure

Heart Failure (HF) is a chronic, progressive condition in which the heart muscle is unable to pump sufficient blood to meet the body's needs for blood and oxygen. It can result from coronary artery disease, previous heart attack, high blood pressure, valvular disease, or cardiomyopathy. Heart failure with reduced ejection fraction (HFrEF) represents a significant subset of patients requiring specialized therapeutic interventions.

Atrial Fibrillation

Atrial Fibrillation (AF) is the most common cardiac arrhythmia, characterized by rapid and irregular beating of the atrial chambers of the heart. This condition significantly increases the risk of stroke, heart failure, and other cardiovascular complications. AF can be paroxysmal (episodic), persistent, or permanent, and requires careful management of both rhythm control and anticoagulation strategies.

Coronary Artery Disease

Coronary Artery Disease (CAD) and Acute Coronary Syndromes (ACS) encompass a spectrum of conditions caused by reduced blood flow to the heart muscle, ranging from stable angina to unstable angina, myocardial infarction (heart attack), and sudden cardiac death. These conditions result from atherosclerotic plaque buildup in coronary arteries, which can lead to partial or complete vessel obstruction.

Hypertension

Hypertension (high blood pressure) is a chronic medical condition characterized by persistently elevated blood pressure in the arteries. It is a major risk factor for cardiovascular disease, stroke, kidney disease, and other serious health complications. Resistant hypertension, defined as blood pressure that remains above goal despite treatment with three or more antihypertensive medications, represents a particularly challenging patient population.

Interested in Collaboration?

Are you a sponsor or research organization planning a cardiology clinical trial in Poland? Contact our clinical trials team to discuss feasibility and site capabilities.

Back to Therapeutic Areas